2009
DOI: 10.1136/hrt.2009.184507
|View full text |Cite
|
Sign up to set email alerts
|

Coronary collateral growth by external counterpulsation: a randomised controlled trial

Abstract: ECP appears to be effective in promoting coronary collateral growth. The extent of collateral function improvement is related to the amount of improvement in the systemic endothelial function.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
57
0
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(61 citation statements)
references
References 18 publications
1
57
0
3
Order By: Relevance
“…Interestingly, two noninvasive therapeutic approaches to increase FSS in the coronary vascular network are being tested to promote collateral flow: physical reeducation (under trial, ref. 98) and external counterpulsation with pneumatic cuffs (99,100).…”
Section: Collateral Growth and Flow-dependent Remodelingmentioning
confidence: 99%
“…Interestingly, two noninvasive therapeutic approaches to increase FSS in the coronary vascular network are being tested to promote collateral flow: physical reeducation (under trial, ref. 98) and external counterpulsation with pneumatic cuffs (99,100).…”
Section: Collateral Growth and Flow-dependent Remodelingmentioning
confidence: 99%
“…5 ECP has been demonstrated to improve the perfusion of vital organs through diastolic augmentation. 6 Myocardial perfusion and coronary collateral flow in patients with coronary artery disease significantly increased after ECP, [7][8][9] which may contribute to clinical benefits of ECP. Hypertension is a well-known risk factor for first or recurrent stroke, [10][11][12] but the blood pressure management in acute stroke is controversial in recent years.…”
mentioning
confidence: 99%
“…5 In regard to the collective prognostic impact of collaterals, the cumulative 10-year survival rates of patients with chronic stable CAD are significantly higher in patients with versus those without sufficient collaterals or high collateral relative to normal flow (collateral flow index [CFI]; Figure 5). 11 On the basis of these prognostic benefits and the given therapeutic options of collateral growth promotion (termed arteriogenesis) 12,13 and in the context of frequently unfeasible conventional revascularization options, an individual quantitative assessment of collateral function is important. The purpose of this article is to review the theoretical background and the different methods for assessment of collateral function, with a specific focus on quantitative methods (for a summary, see the Table).…”
mentioning
confidence: 99%